Perioperative Blood Management: Pros and Cons of ANH and Cell Salvage

Sangkeun Ahn, Jong Hyun Lee
{"title":"Perioperative Blood Management: Pros and Cons of ANH and Cell Salvage","authors":"Sangkeun Ahn, Jong Hyun Lee","doi":"10.7599/HMR.2018.38.1.27","DOIUrl":null,"url":null,"abstract":"Without doubt, allogenic blood transfusion has been an important lifesaving option in some circumstances. However, allogenic blood transfusion also has its drawbacks. Side effects of allogenic blood transfusion, blood scarcity and individual religion problem like Jehovah’s witnesses are major issues [1,2]. In this respect, there has been much effort to replace allogenic blood transfusion such as using pharmacological agent, injecting topical vasoconstrictive agent, induced hypotension, intravenous iron, erythropoietin, coagulant and so on [3]. In addition, with growing technology, Cell salvage and Acute normovolemic hemodilution (ANH) has emerged as a substitute for allogenic blood transfusion [3,4]. First, Cell salvage became widely known in the late 1970s due to the infection threat like viral hepatitis and HIV infection from allogenic blood transfusion [5]. Namely, it was introduced in an optimal time to the world. Even now, cell salvage is a useful and effective technique with a low risk of transfusion-borne infection. Second, ANH has been utilized and its efficacy studied since the 1960s [6,7]. ANH is also considered to be helpful in cutting back the volume of allogenic blood transfusion and transfusion of autologous whole blood [8]. Nonetheless, still the efficacy and utility of ANH and cell salvage is unclear with pros and cons due to inconsistent conditions among various articles and outcome from journals ranging from effectiveness to insignificance or being unthrifty when considering other facilities. Hence, through this study, we provide clinical information about procedures mentioned above, gather various articles about cell salvage and ANH and make a conclusion whether cell salvage and ANH is effective or Review","PeriodicalId":345710,"journal":{"name":"Hanyang Medical Reviews","volume":"45 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hanyang Medical Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7599/HMR.2018.38.1.27","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Without doubt, allogenic blood transfusion has been an important lifesaving option in some circumstances. However, allogenic blood transfusion also has its drawbacks. Side effects of allogenic blood transfusion, blood scarcity and individual religion problem like Jehovah’s witnesses are major issues [1,2]. In this respect, there has been much effort to replace allogenic blood transfusion such as using pharmacological agent, injecting topical vasoconstrictive agent, induced hypotension, intravenous iron, erythropoietin, coagulant and so on [3]. In addition, with growing technology, Cell salvage and Acute normovolemic hemodilution (ANH) has emerged as a substitute for allogenic blood transfusion [3,4]. First, Cell salvage became widely known in the late 1970s due to the infection threat like viral hepatitis and HIV infection from allogenic blood transfusion [5]. Namely, it was introduced in an optimal time to the world. Even now, cell salvage is a useful and effective technique with a low risk of transfusion-borne infection. Second, ANH has been utilized and its efficacy studied since the 1960s [6,7]. ANH is also considered to be helpful in cutting back the volume of allogenic blood transfusion and transfusion of autologous whole blood [8]. Nonetheless, still the efficacy and utility of ANH and cell salvage is unclear with pros and cons due to inconsistent conditions among various articles and outcome from journals ranging from effectiveness to insignificance or being unthrifty when considering other facilities. Hence, through this study, we provide clinical information about procedures mentioned above, gather various articles about cell salvage and ANH and make a conclusion whether cell salvage and ANH is effective or Review
围手术期血液管理:ANH和细胞抢救的利弊
毫无疑问,在某些情况下,同种异体输血是一种重要的救命方法。然而,同种异体输血也有其缺点。异体输血的副作用、血液短缺和耶和华见证人等个人宗教问题是主要问题[1,2]。在这方面,已有很多替代同种异体输血的方法,如使用药物、局部注射血管收缩剂、诱导性降压、静脉注射铁、促红细胞生成素、凝血剂等[3]。此外,随着技术的发展,细胞挽救和急性等容血稀释(ANH)已经成为同种异体输血的替代品[3,4]。首先,20世纪70年代末,由于异体输血引起的病毒性肝炎和HIV感染等感染威胁,细胞挽救术开始广为人知[5]。也就是说,它是在一个最佳的时间引入世界的。即使是现在,细胞抢救也是一种有用和有效的技术,输血传播感染的风险很低。其次,自20世纪60年代以来,ANH就开始被利用并研究其疗效[6,7]。ANH也被认为有助于减少异体输血量和自体全血输血量[8]。尽管如此,由于各种文章和期刊的结果不一致,从有效到不重要或在考虑其他设施时不节俭,ANH和细胞回收的功效和效用仍然不清楚,利弊不一。因此,通过本研究,我们提供上述程序的临床信息,收集各种关于细胞挽救和ANH的文章,并得出细胞挽救和ANH是否有效或审查的结论
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信